Modelling head and neck cancer costs over 10 years

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Serum Cytokine Profile in Alzheimer's Disease Patients After Ingestion of an Antioxidant Beverage

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1233-1241

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer's Disease and Other Dementias

By Hill Jerrold  

PharmacoEconomics, Vol. 24, Iss. 3, 2006-01 ,pp. : 265-280

Adis International

Access to resources Recommend Favorite

The Epidemic of Alzheimer's Disease: How Can We Manage the Costs?

By Johnson N.  

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 215-223

Adis International

Access to resources Recommend Favorite

Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience

By  

Current Medicinal Chemistry, Vol. 18, Iss. 8, 2011-03 ,pp. : 1230-1238

Bentham Science Publishers

Access to resources Recommend Favorite